Published in Lancet on October 15, 1988
Rubella. Lancet (2015) 1.16
Rubella vaccines: past, present and future. Epidemiol Infect (1991) 1.07
Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees. Cytokine (2010) 1.06
Rubella antibody screening during pregnancy in an urban area of Northern Italy. Infect Dis Rep (2012) 0.85
Persistence and titer changes of rubella virus antibodies in primiparous women who had been vaccinated with strain RA 27/3 in junior high school. Clin Vaccine Immunol (2011) 0.77
Reasons for rubella susceptibility among pregnant women in west Lambeth. J R Soc Med (1994) 0.75
A closely linked genetic marker for cystic fibrosis. Nature (1985) 7.85
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
The impact of smoke-free workplaces on declining cigarette consumption in Australia and the United States. Am J Public Health (1999) 4.84
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
HIV seroprevalence among women attending antenatal clinics in London. Lancet (1992) 4.46
Serum IgM and IgG responses in postnatally acquired rubella. Lancet (1969) 4.16
A serological method for demonstrating recent infection by rubella virus. Br Med J (1967) 4.07
Hepatitis A. BMJ (1991) 3.77
Immunization against rubella. A study to determine the place of rubella vaccination as a selective procedure in a comprehensive immunization programme. Practitioner (1971) 3.50
Rubella vaccination of schoolgirls: factors affecting vaccine uptake. Br Med J (1977) 2.96
Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81
A mapped set of genetic markers for human chromosome 9. Genomics (1988) 2.80
Rapid diagnosis of tuberculous meningitis by latex particle agglutination. Lancet (1984) 2.78
Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. BMJ (1992) 2.76
Liver disease among homosexual males. Lancet (1979) 2.74
Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun (2000) 2.71
Why the tobacco industry fears the passive smoking issue. Int J Health Serv (1990) 2.59
An outbreak of rotavirus infection in a long-stay ward of a geriatric hospital. J Clin Pathol (1980) 2.52
The immunoglobulins in congenital rubella. Lancet (1966) 2.51
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens. J Clin Microbiol (1993) 2.45
Serological assessment of rubella during pregnancy. Br Med J (1970) 2.37
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med (1990) 2.32
In-vitro detection of human rotaviruses. Lancet (1975) 2.28
Routine use of mu-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections. J Med Virol (1986) 2.21
Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
Clinical and laboratory studies with rubella vaccines in adults. Br Med J (1969) 2.07
Persistence of rubella antibody with and without embryopathy. A follow-up study of children exposed to maternal rubella. Br Med J (1965) 2.01
Biogeographical patterns and determinants of invasion by forest pathogens in Europe. New Phytol (2012) 2.01
Hepatitis B infections after gynaecological surgery. Lancet (1989) 1.99
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99
Temporal relations between maternal rubella and congenital defects. Lancet (1987) 1.94
Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet (1983) 1.94
Asymptomatic endemic rotavirus infections in the newborn. Lancet (1978) 1.93
Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health (1989) 1.92
Letter: Rotavirus infections in a maternity unit. Lancet (1975) 1.92
Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86
The effect of trypsin on the growth of rotavirus. J Gen Virol (1978) 1.86
Hepatitis B vaccine boosting among young healthy adults. Lancet (1994) 1.85
Parity of women contracting rubella in pregnancy. Implications with respect to rubella vaccination. Lancet (1976) 1.82
Bereavement counselling after sudden infant death. Br Med J (Clin Res Ed) (1985) 1.79
Medical students' risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ (1999) 1.79
Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ (1995) 1.78
Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM. Lancet (1975) 1.78
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet (1972) 1.73
Rotavirus infections in a maternity unit. Arch Dis Child (1976) 1.71
Delayed detection of congenital hearing loss in high risk infants. BMJ (1990) 1.71
Detection of enterovirus RNA in clinical samples by nested polymerase chain reaction for rapid diagnosis of enterovirus infection. J Virol Methods (1994) 1.67
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Letter: Rubella-specific IgM and a new inhibitor. Br Med J (1974) 1.66
Further linkage data on cystic fibrosis: the Utah Study. Am J Hum Genet (1986) 1.63
A case of Lassa fever: experience at St Thomas's Hospital. Br Med J (Clin Res Ed) (1982) 1.59
Maternal rubella and its effect on the foetus. Arch Dis Child (1967) 1.59
Clinical evaluation of the turkey-erythrocyte passive-haemagglutination test for hepatitis-B surface antigen. Lancet (1974) 1.59
Hepatitis B vaccine uptake among surgeons at a London teaching hospital: how well are we doing? Ann R Coll Surg Engl (1996) 1.58
Rubella vaccine trials in adults and children. Comparison of three attenuated vaccines. Am J Dis Child (1969) 1.58
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
Antibodies to fastidious faecal adenoviruses (species 40 and 41) in sera from children. J Med Virol (1983) 1.57
Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol (1970) 1.56
Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab (1995) 1.55
Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet (1980) 1.54
Hemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr (1989) 1.50
Herpes genitalis; clinical and virological studies. Br J Vener Dis (1967) 1.50
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
The control of diphtheria, tetanus, poliomyelitis, measles, rubella and mumps. Practitioner (1975) 1.45
Impactitis: new cures for an old disease. J Clin Pathol (2001) 1.42
An outbreak of rotavirus infection among adults in a cardiology ward. J Infect (1980) 1.40
bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40
Community perceptions about the tobacco industry and tobacco control funding. Aust N Z J Public Health (1999) 1.40
Quantitation of HIV: correlation with clinical, virological, and immunological status. J Med Virol (1991) 1.40
Letter: Polio vaccination for travellers. Br Med J (1975) 1.39
Measles must go and with it rubella. Br Med J (Clin Res Ed) (1987) 1.38
Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol (1994) 1.38
Veterinary nursing examinations. Vet Rec (1994) 1.38
Alpha 2-adrenergic mechanism in menopausal hot flushes. Obstet Gynecol (1990) 1.37
Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33
Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest (1986) 1.33
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33
Measles vaccines. Br Med Bull (1969) 1.32
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32